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Introduction
Degos’ disease is a rare disorder with multisystem involve-
ment and unknown etiology. This entity was first de-
scribed by Degos in 1942 (1,2). Other synonyms for this
disease are malignant atrophic papulosis, atrophic papu-
losquamous dermatitis, fatal cutaneous-intestinal syn-
drome, and thromboangiitis cutaneointestinalis dissemi-
nata (3). It has been more commonly reported in whites,
men, and those in the third decade of life, although onset
age ranges from 3 weeks to 67 years (4). The average course
of the disease is reported to be around 2 years (1), but case
reports of patients with a benign variant have been re-
ported with survival of 14 years (5). Death is most com-
monly due to intestinal perforation or cerebral infarction.
We report a fatal case of Degos’ disease that presented with
abdominal pain and intestinal perforations, which clini-
cally mimicked vasculitis.
Case report
A 49-year-old white woman initially developed painful
oral ulcers and a maculopapular rash over her back, ex-
tremities, and trunk in April 1999. She then developed
abdominal pain in March 2000 and underwent an evalua-
tion that included colonoscopy and gastroscopy with bi-
opsies, both of which were nondiagnostic. Five months
later, the patient presented with a temperature of 103.5°F
and an acute abdomen. Multiple maculopapular lesions
with central pallor and an erythematous margin were ob-
served on extremities, chest, and back. An abdominal com-
puted tomography scan demonstrated free fluid, so she
underwent exploratory laparotomy and small bowel resec-
tion due to perforating ulcers in the jejunum. Three weeks
later, she had recurrent abdominal pain and underwent
another exploratory laparotomy and bowel resection for 3
perforations involving the jejunum and ileum. Two days
later, she underwent laparotomy again, this time a cya-
notic distal ileum was revealed and resected. Histopathol-
ogy showed severe necrotizing enteritis with interstitial
hemorrhage, possibly ischemic, and acute serositis. Mul-
tiple vessels with thrombosis were seen, but inflammation
was rare, and suggested the possibility of vasculitis. Cy-
clophosphamide and methylprednisolone were adminis-
tered for presumed vasculitis. Infliximab therapy was also
initiated. Enoxaparin was initiated due to concern of mes-
enteric thrombosis. The patient subsequently underwent
revisions of the enterostomies. The biopsies and skin le-
sions were then found to be consistent with Degos’ disease
(Figure 1) and immunosuppressants were discontinued.
She was then transferred to our institution for manage-
ment in October 2000.
Past medical history included nonmetastatic breast can-
cer treated in 1990 with modified radical mastectomy,
chemotherapy, and radiation therapy; hypertension; gas-
troesophageal reflux; atrial fibrillation; depression; and os-
teoporosis.
Relevant laboratory results were elevated C-reactive pro-
tein at 8.7 mg/dl (0–0.6) and rheumatoid factor at 85 IU/ml
(0–30). Antiphospholipid antibody, dilute Russell viper
venom time, protein C antigen, protein S antigen, angio-
tensin converting enzyme, antinuclear antibody, and an-
tineutrophil cytoplasmic antibody were all negative or
within normal ranges.
The patient’s skin lesions and abdominal symptoms im-
proved with intravenous dipyramidole (25 mg every 12
hours) and indomethacin (50 mg twice daily per rectum).
Enoxaparin was discontinued because gastrointestinal
bleeding was observed. She had no further recurrence of
intestinal perforations and, being clinically stable, was
discharged in November 2000. She subsequently moved
out of state. However 3 months later, the patient developed
pleural effusions, acute respiratory distress, and was given
vasopressors. She developed abdominal symptoms similar
to those experienced before and she died. An autopsy was
not performed.
Discussion
Degos’ disease is a rare vasculopathy involving multiple
organ systems. The internal organs most commonly in-
volved in the order of decreasing frequency are the gastro-
intestinal tract, central nervous system, thoracic organs,
eyes, oral mucosa, and kidneys (6). Involvement of the
bladder, pleura, and pancreas have also been reported (1).
The most common initial presentation is the classic skin
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eruption, followed after months to years by involvement of
the internal organs. The typical skin lesion is seen primar-
ily in the trunk and extremities and is described as mac-
ulopapular, umbilicated with a porcelain central area of
necrosis and erythematous margins (3). Gastrointestinal
tract involvement is seen in 47% of the patients (7) with
clinical manifestations ranging from dyspepsia to an acute
surgical abdomen with perforated viscus (4). It has also
been suggested that endoscopy be performed routinely in
all patients to detect asymptomatic silent perforations,
even in those who do not have apparent gastrointestinal
involvement (8). Central nervous system involvement is
seen with hemiparesis, myelopathy, polyradiculopathy,
visual disorders, and subsequently mental deterioration
and cranial nerve palsies (9).
The etiology and pathogenesis of Degos’ disease are still
unknown. The etiology is speculated to be immunologic
dysfunction, coagulation or fibrinolysis disturbances, or
possibly viral infections (10). Histopathologically, in-
volvement of small arteries, arterioles, and venous lesions
have been described. There is intimal involvement with
endothelial swelling, proliferation, infiltration of mononu-
clear cells, fibrosis, thrombus formation, and fibrin depo-
sition (11). Multiple infarctive and thrombotic lesions may
be seen and sometimes misdiagnosed as vasculitic lesions.
However, the distinction is intimal proliferation with
sparse inflammation around the affected vessels and the
elastica, media, or adventitita being devoid of pathology
(12). Immune complexes also have not been detected in
most cases reported (13).
The diagnosis is mainly a clinicopathologic correlation.
The typical skin lesions and internal organ involvement
should alert a physician to this disease. Unfortunately,
treatment options for Degos’ disease are limited. Immuno-
suppressant therapy, anticoagulants, and plasma exchange
have been tried but not proven to be effective (4). The
antiplatelet agents aspirin and dipyramidole have been
suggested to retard the process, but may contribute to risk
of gastrointestinal and intracranial hemorrhage (14,15).
Thus it is important for physicians, especially rheuma-
tologists, to be aware of the spectrum of the various clin-
ical findings in Degos’ disease and be vigilant because this
can be mistaken for vasculitis. Furthermore, it is also im-
portant to consider this disease when vasculitis has been
diagnosed but is not responding to immunosuppressive
therapy.
Figure 1. The typical skin lesion in Degos’ disease, as seen in our patient, is described as maculopapular 2–5 mm, umbilicated, with
a porcelain white center and erythematous margins (Panel A). Small intestine biopsy in this patient demonstrated vascular changes
consistent with Degos’ disease: rare inflamed vessels (Panel B), occlusion of vascular lumens by fibrointimal proliferation and
organized fibrin thrombi (Panel C), and atrophy of vessel wall with fibrin deposition (Panel D).
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